Deborah Zell
About
In The Last Decade
Deborah Zell
16 papers receiving 417 citations
Peers
Comparison fields: 5 of 67
- Dermatology 293
- Surgery 145
- Rehabilitation 107
- Epidemiology 97
- Oncology 60
Countries citing papers authored by Deborah Zell
This map shows the geographic impact of Deborah Zell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Zell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Zell more than expected).
Fields of papers citing papers by Deborah Zell
This network shows the impact of papers produced by Deborah Zell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Zell. The network helps show where Deborah Zell may publish in the future.
Co-authorship network of co-authors of Deborah Zell
This figure shows the co-authorship network connecting the top 25 collaborators of Deborah Zell. A scholar is included among the top collaborators of Deborah Zell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah Zell. Deborah Zell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 8 | |
| 3 | 40 | |
| 4 | A comparative study evaluating the tolerability and efficacy of two topical therapies for the treatment of keloids and hypertrophic scars. | 38 |
| 5 | 15 | |
| 6 | 8 | |
| 7 | 3 | |
| 8 | 30 | |
| 9 | Evaluating the tolerability and efficacy of etanercept compared to triamcinolone acetonide for the intralesional treatment of keloids. | 19 |
| 10 | 3 | |
| 11 | 41 | |
| 12 | 132 | |
| 13 | 31 | |
| 14 | 33 | |
| 15 | Immunological strategies to fight skin cancer. | 10 |
| 16 | Subantimicrobial dose doxycycline: a unique treatment for rosacea. | 15 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.